Company intelligence / Profile preview

Merida Capital Partners

New York City, New York, United States

Ownership: Private
Employees: ~19
Development stage: Other

Overview

Merida Capital Partners is a leading cannabis-focused private equity firm investing in cultivation tech, products and services in the broader legal cannabis ecosystem, with direct exposure to medical and pharma verticals via portfolio companies; does not operate therapeutics/products or clinical programs itself.

Therapeutic areas: ImmunologyNeurologyPsychiatry
Modalities: plant-based medicinescannabis-derived pharmaceuticals
Industry: Investors

Partnerships

Mode (smart cannabis dosing device partnership)Explorer Equity GroupClean Pacific VenturesPresidio View CapitalNavy CapitalJW Asset ManagementGotham Green Partners

Beyond the preview

Go deeper on Merida Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Merida Capital Partners.

Explore the full profile